Epidemiology and natural history of multiple sclerosis: new insights

被引:106
作者
Kantarci, Orhun
Wingerchuk, Dean
机构
[1] Mayo Clin, Coll Med, Dept Neurol, Scottsdale, AZ 85259 USA
[2] Mayo Clin & Mayo Fdn, Coll Med, Dept Neurol, Rochester, MN 55905 USA
关键词
environmental factors; epidemiology; genetic factors; longitudinal studies; multiple sclerosis; natural history;
D O I
10.1097/01.wco.0000227033.47458.82
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review The cause of multiple sclerosis remains elusive. We review recent epidemiological, studies of genetic and environmental factors that influence susceptibility to the disease and its clinical course. Recent findings Genetic advances strengthen the association of multiple sclerosis with the human leukocyte antigen (HLA)-DRB1 allele and interferon-gamma polymorphisms and suggest that apolipoprotein E alleles play an imortant role. In the p environmental realm, nested case-control studies show that prior Epstein-Barr virus exposure is overrepresented in 1, multiple sclerosis. Smoking has been associated with both risk of multiple sclerosis and progressive disease. Vitamin D deficiency might tie together environmental clues with higher multiple sclerosis prevalence rates; dietary vitamin supplementation is also associated with reduced multiple, sclerosis risk. Natural history studies demonstrated dissociation between relapses and disease progression, facilitated the ability to distinguish neuromyelitis optica and related syndromes from typical multiple sclerosis, and spawned,the exploration of large datasets to model longterm disease activity. Summary Our understanding of the contributions of specific genetic and environmental factors that contribute to multiple sclerosis has improved. Further refinements will eventually allow powerful longitudinal studies to assess genetic and environmental interactions with implications for prediction of individual disease susceptibility, clinical course, and response to therapy.
引用
收藏
页码:248 / 254
页数:7
相关论文
共 84 条
[1]
Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves [J].
Achiron, A ;
Polliack, M ;
Rao, SM ;
Barak, Y ;
Lavie, M ;
Appelboim, N ;
Harel, Y .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (05) :744-749
[2]
Beck RW, 2003, ARCH OPHTHALMOL-CHIC, V121, P944
[3]
No evidence for genetic linkage between development of multiple sclerosis and components of the IFN system and the JAK-STAT pathway [J].
Bergkvist, M ;
Olsson, M ;
Sandberg-Wollheim, M .
MULTIPLE SCLEROSIS, 2004, 10 (01) :87-88
[4]
Cigarette smoking and multiple sclerosis (MS): Yet another reason to quit [J].
Brey, RL .
NEUROLOGY, 2003, 61 (08) :E11-E12
[5]
HLA-DR,DQ and APOE genotypes and gender influence in Sardinian primary progressive MS [J].
Cocco, E ;
Sotgiu, A ;
Costa, G ;
Murru, MR ;
Mancosu, C ;
Murru, R ;
Lai, M ;
Contu, P ;
Marrosu, MG .
NEUROLOGY, 2005, 64 (03) :564-566
[6]
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process [J].
Confavreux, C ;
Vukusic, S ;
Adeleine, P .
BRAIN, 2003, 126 :770-782
[7]
*CONS IMSG, 2005, AM J HUM GENET, V77, P454
[8]
A systematic review of several potential non-genetic risk factors for multiple sclerosis [J].
Coo, H ;
Aronson, KJ .
NEUROEPIDEMIOLOGY, 2004, 23 (1-2) :1-12
[9]
Prospective study of patients presenting with acute partial transverse myelopathy [J].
Cordonnier, C ;
de Seze, J ;
Breteau, G ;
Ferriby, D ;
Michelin, E ;
Stojkovic, T ;
Pruvo, JP ;
Vermersch, P .
JOURNAL OF NEUROLOGY, 2003, 250 (12) :1447-1452
[10]
The natural history of multiple sclerosis: a geographically based study - 5. The clinical features and natural history of primary progressive multiple sclerosis [J].
Cottrell, DA ;
Kremenchutzky, M ;
Rice, GPA ;
Koopman, WJ ;
Hader, W ;
Baskerville, J ;
Ebers, GC .
BRAIN, 1999, 122 :625-639